All In Biotech

Free tool

FAERS Monitor: Orapred Odt

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 021959 or its brand name (Orapred Odt, Prednisolone Sodium Phosphate). Reports on generic versions are filed under their own applications.

Reports

2,487

Serious

2,172

87% of reports

Hospitalization

855

Death reported

469

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective215
  • off label use196
  • pyrexia190
  • vomiting183
  • condition aggravated170
  • pneumonia159
  • treatment failure156
  • fatigue150
  • headache150
  • pain149
  • asthma144
  • hypersensitivity136
  • rheumatoid arthritis130
  • dyspnoea122
  • rash115

Reports by year received

View as table
YearReports
200423
200526
200677
2007138
200887
200915
201014
201128
201228
201322
201422
201526
201658
2017234
2018424
2019181
2020213
202183
2022167
2023177
2024138
2025168
2026138

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,051,672 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
treatment failureSignal15616.013.72,176
asthmaSignal14410.89.21,274
rheumatoid arthritisSignal1309.78.21,009
hypersensitivitySignal1366.25.3593
condition aggravatedSignal1704.74.1503
pyrexiaSignal1904.64.1549
pneumoniaSignal1594.23.6383
vomitingSignal1833.32.9296
rashSignal1152.21.979
painSignal1492.11.882
headacheSignal1502.01.779
off label use1961.91.785
dyspnoea1221.81.546
fatigue1501.61.437
drug ineffective2151.41.224

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.